Newly released emails reveal that top National Institutes of Health (NIH) officials had concerns about researchers studying individuals experiencing neurological issues after COVID-19 vaccination. Dr. Avindra Nath was investigating these post-vaccination neurological problems and shared findings in a draft paper. His draft suggested early treatment could reverse symptoms. NIH Director Dr. Walter Koroshetz forwarded the manuscript to Dr. Anthony Fauci, noting a stream of reports on post-vaccination neurological conditions. Another NIH employee sent the paper to then-NIH Director Dr. Francis Collins and Dr. Lawrence Tabak, mentioning rejection by the New England Journal of Medicine. Collins questioned the referral process for the patients and expressed concern about feeding vaccine hesitancy. Tabak privately suggested Koroshetz should "shut this down." The paper was ultimately released as a preprint without peer review over a year later. One patient examined by Nath's team felt dismissed without explanation, suspecting interference from leadership. The emails raise questions about whether NIH leadership prioritized vaccine confidence over publication.